|
|
|
Insider
Information: |
Ignelzi Troy A. |
Relationship: |
|
City: |
Plymouth |
State: |
MI |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
30,487 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
30,487 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Scpharmaceuticals Inc. |
SCPH |
|
|
0 |
|
0 |
Premium* |
|
Karuna Therapeutics, Inc. |
KRTX |
|
2023-08-22 |
30,487 |
2020-03-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
|
2022-02-15 |
4 |
OE |
$9.20 |
$13,800 |
D/D |
1,500 |
26,470 |
0 |
- |
|
KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
|
2022-04-19 |
4 |
OE |
$9.20 |
$32,200 |
D/D |
3,500 |
28,470 |
0 |
- |
|
KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
|
2022-04-20 |
4 |
OE |
$9.20 |
$6,477 |
D/D |
704 |
25,674 |
0 |
- |
|
KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
|
2022-04-21 |
4 |
OE |
$9.20 |
$368 |
D/D |
40 |
25,010 |
0 |
- |
|
KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
|
2022-08-09 |
4 |
OE |
$9.20 |
$151,800 |
D/D |
16,500 |
41,470 |
0 |
- |
|
KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
|
2022-11-15 |
4 |
OE |
$9.20 |
$151,800 |
D/D |
16,500 |
26,470 |
0 |
- |
|
KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
|
2022-12-16 |
4 |
OE |
$9.20 |
$109,176 |
D/D |
11,867 |
21,837 |
0 |
- |
|
KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
|
2023-01-17 |
4 |
OE |
$9.20 |
$7,516 |
D/D |
817 |
22,654 |
0 |
- |
|
KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
|
2023-01-18 |
4 |
OE |
$9.20 |
$1,840 |
D/D |
200 |
22,037 |
0 |
- |
|
KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
|
2023-02-21 |
4 |
OE |
$9.20 |
$55,200 |
D/D |
6,000 |
36,487 |
0 |
- |
|
KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
|
2023-05-23 |
4 |
OE |
$9.20 |
$82,800 |
D/D |
9,000 |
39,487 |
0 |
- |
|
KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
|
2023-08-22 |
4 |
OE |
$9.20 |
$13,800 |
D/D |
1,500 |
31,987 |
0 |
- |
|
KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
|
2022-09-30 |
4 |
S |
$227.05 |
$2,403,017 |
D/D |
(10,500) |
14,470 |
0 |
- |
|
KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
|
2022-10-03 |
4 |
S |
$230.02 |
$947,820 |
D/D |
(4,100) |
10,370 |
0 |
- |
|
KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
|
2022-10-04 |
4 |
S |
$233.20 |
$93,280 |
D/D |
(400) |
9,970 |
0 |
- |
|
65 Records found
|
|
Page 3 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|